Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
30,179 total articles
Morgan Stanley published NielsenIQ All Measured Outlets sales figures for the most recent four-week period, revealing a modest acceleration in overall pet category growth versus the prior 12-week trend and divergent company-level results across pet food and cat litter. The dataset, which now incorporates additional retail channels such as Costco, x…
Globalstar shares moved lower in pre-market trade following a downgrade from Craig-Hallum and fresh evidence of significant insider selling. The company also reported a Q2 2026 EPS loss that fell short of expectations, while operational progress on satellite replenishment continued with the deployment of eight replacement satellites under a major c…
H & M Hennes & Mauritz B shares climbed after Citi placed the stock on a positive catalyst watch and raised its price target, while the Persson family disclosed a multi-million share purchase. The gains appear driven by these company-specific developments rather than a broader market rally ahead of the retailer’s third-quarter results next month.
Citi upgraded Bath & Body Works from Neutral to Buy ahead of the retailer's upcoming second-quarter report, forecasting an earnings-per-share beat and highlighting a depressed share price, recent product momentum and possible upside from lower energy costs and tariff refunds as drivers of a favorable risk/reward profile.
Berenberg upgraded Sixt SE to Buy from Hold following encouraging second-quarter results and growing European travel demand. The broker raised price targets for both ordinary and preference shares and increased revenue and earnings forecasts for 2026-2028, citing stronger assumptions for Europe and a clearer U.S. residual-value approach. Sixt share…
U.S. stock futures opened lower as renewed U.S.-Iran tensions pushed oil prices up, reviving concerns that energy-driven inflation could limit Federal Reserve easing. In premarket trading, a mix of analyst upgrades, corporate earnings and clinical trial developments produced sharp moves across select technology, biotech and small-cap names.
Mizuho has downgraded Norwegian Cruise Line Holdings (NCLH) to Neutral from Outperform and cut its price target to $17 from $22. The brokerage highlighted operational missteps it described as "self-inflicted wounds," alongside macro headwinds, and flagged a potential funding shortfall and rising leverage over the next 18 months.
Einride shares jumped sharply in pre-market trading following an announcement that the company will deploy 500 Tesla Semi trucks across major North American freight corridors, managed via its Saga AI fleet intelligence platform. The phased rollout, financed by third parties and beginning September 2026, would triple Einride's current electric truck…
UBS downgraded French reinsurer Scor to sell from neutral and trimmed its price target to €32.50, warning that catalysts in September and December could pressure consensus forecasts, corporate distributions and valuation multiples. The bank reduced earnings estimates, expects stronger scrutiny of terms and conditions at upcoming industry meetings, …
Amer Sports rose sharply in pre-market trade after reporting second-quarter 2026 results that beat modest seasonal expectations. The surprise beat followed a pattern of recent upside surprises, comes amid uniform buy ratings and a high consensus price target, and coincided with unusually large pre-earnings call option volume. The move was company-s…
Bath & Body Works shares climbed 2.6% in pre-market trading after Citi moved the stock from Neutral to Buy, assigning a $31.24 fair value. The upgrade arrives with Q2 2026 results due before the market opens tomorrow and a quarterly cash dividend of $0.20 per share that carries an ex-dividend date of August 21, combining to focus investor attention…
Salesforce reports Q2 FY27 results after the close on August 26. The shares have traded down despite four consecutive quarters of EPS outperformance, as investors seek proof that management can drive a 2H reacceleration and restore net-new customer momentum. Valuation metrics - a 13.2x forward P/E and a 9.4% free cash flow yield - imply the market …
Jefferies upgraded Kingspan to buy from hold and increased its price target to €140, projecting stronger-than-consensus 2027 sales, trading profit and EPS. The broker highlights growth at Advnsys, supported by the recent BMC acquisition, as the main catalyst for higher estimates and anticipates material margin and EBITDA expansion by 2028.
Frasers Group has increased its holding in Hugo Boss to nearly 48% after launching a voluntary cash offer earlier this year. The offer, priced at €38 per share, followed Frasers' initial 26.06% stake and has prompted a firm rejection from Hugo Boss executives who called the bid financially inadequate. Hugo Boss says it will continue executing a str…
Wolfe Research reported July 2026 credit and loan growth data for American Express, Bread Financial, Capital One and Synchrony. Aggregate card balances expanded 3.0% year-over-year, down from 3.7% in June, with Prime Day timing cited as a potential contributor to the slowdown. Delinquency rates rose modestly month-over-month while net charge-offs d…
SoftBank Group is reportedly preparing a roughly one trillion yen ($6.26 billion) bond sale targeted at retail investors in Japan, a move that would be the largest-ever corporate retail bond issuance in the country. The notes are expected to carry a seven-year maturity and pay interest in the upper 4% range, according to Nikkei, with final terms to…
Sixt SE shares rose 3.6% to €74 after Berenberg upgraded ordinary shares from Hold to Buy and raised its price target to €91. The upgrade follows Sixt's 20th straight record quarter and first-half revenue above €2.1 billion, with earnings before taxes up nearly 40% year-over-year and management reaffirming full-year guidance.
Lanxess shares declined sharply after BNP Paribas Exane downgraded the German specialty chemicals group and set a price objective that signals significant further downside. The move compounded caution following a second-quarter report showing only marginal EBITDA growth and management comments that demand conditions have not improved.
Oxford BioMedica shares declined as the company trimmed its 2026 revenue outlook, with the market focusing on short-term order patterns and the phased ramp-up of its Durham, North Carolina manufacturing site. Analysts remain generally positive, but investors are awaiting clearer proof that customer ordering is stabilising and that the U.S. facility…
Basilea Pharmaceutica's stock climbed sharply after the company reported first-half 2026 results that outpaced expectations, and issued a materially upgraded full-year outlook. Revenue and profit gains were accompanied by confirmation that its late-stage antifungal candidate remains on schedule, prompting investor reassessment despite broader marke…
Hemnet shares climbed sharply after JPMorgan moved its rating from Underweight to Overweight and raised its price target to SEK 126 from SEK 81. The upgrade reversed a prior November 2025 downgrade and rested on a view that valuation is now attractive and that listing volumes - a key operating metric - should rebound over the next year. The stock's…
SKAN rallied after reporting H1 2026 results that outperformed expectations across top-line growth, margins and orders. Revenue rose to CHF 164.5 million, the company swung to a net profit of CHF 5.4 million, and order intake and backlog expanded materially. Management reiterated full-year targets, while regulatory clearance for a new services offe…
Royal Unibrew shares tumbled after the company's H1 2026 interim results revealed an operating profit below analyst expectations. While revenue, diluted EPS and guidance held up and management announced a substantial buyback, the EBIT shortfall spurred a steep market reaction and extended a recent downtrend in the stock.
Coloplast shares rose after the Danish medical device maker posted fiscal Q3 2025/26 results showing 6% organic revenue growth that topped analyst expectations. Broad-based top-line strength, led by Continence Care and U.S. expansion, and unchanged full-year guidance supported a measured share-price rise, while an EBIT margin miss, a decline in Bio…
Synectics PLC shares dropped more than 13% after the security solutions group reported a 37% decline in first-half revenue, driven largely by the non-recurrence of a £7.8 million gaming contract recorded in the prior year and by delays to energy projects related to Middle East disruptions. Management said its strategic transformation remains on tra…
